Skip to content
Clinical ResearchResearch compoundModerate evidence

Vinburnine

Compound once marketed to improve brain circulation (Cervoxan); it widens brain vessels, but modern large human trials are lacking.

NootropicNeuroprotectiveNeuroprotectionVasodilatorAcetylcholinenoo.affects.neuroprotection

Pharmacology

ClassNeuroprotection · Vasodilator
Primary targetCerebral vasodilation and phosphodiesterase inhibition
Targets4 receptor targets
Half-lifeShort, on the order of a few hours, in line with related vinca alkaloids
OnsetEffects within a few hours; typically taken during the day
EvidenceModerate evidence
Affected systemsAcetylcholinenoo.affects.neuroprotection

Contents

DETAILED OVERVIEW

What is Vinburnine?

Vinburnine is a compound of the vinca alkaloid family, known from periwinkle plants, that was used as a medicine to improve circulation in the brain, for example in France under the name Cervoxan. In several countries it has since been withdrawn or restricted, and it is not approved in the United States.

By widening the blood vessels of the brain it may improve blood flow and oxygen supply and make nerve tissue more resistant to a lack of oxygen. In experimental models learning and memory problems improved, and a supportive effect on thinking has been described in older adults. The evidence comes mostly from animal studies and older clinical observations; modern large comparative trials are lacking. Because it widens vessels it can cause dizziness and a drop in blood pressure, and together with blood-pressure medicines this may add up. Safety in pregnancy and breastfeeding has not been established.

Mechanism

Cerebral vasodilation + PDE modulation

Half-life

Short, a few hours (like related vinca alkaloids)

Legal status

Medicine in some markets (Cervoxan), not FDA-approved

Receptor profile

  • Phosphodiesterase (PDE)Moderate
  • Cerebral blood flowModerate
  • Muscarinic acetylcholine receptors (allosteric)Moderate
  • Neuronal metabolism / antihypoxiaWeak

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Dizziness, particularly on standing due to lowered blood pressure
  • Low blood pressure (hypotension) from the vasodilatory effect
  • Occasional gastrointestinal upset, nausea
  • Rare skin reactions: fixed drug eruption reported in a case report
  • Limited safety data from large clinical trials

Contraindications · 4

  • Pregnancy and breastfeeding: safety not established, avoid
  • Low blood pressure or hypotension tendency: the vasodilatory effect may worsen it
  • Co-administration with other blood-pressure-lowering agents: additive hypotension
  • Known hypersensitivity to vinca alkaloids or the compound

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Vinburnine was traditionally used to improve cerebral blood flow (marketed in France as Cervoxan), aiming to widen brain blood vessels and boost oxygen delivery, which in turn helps protect nerve cells from low-oxygen stress. It was mainly described for cognitive support in older adults, and experimental studies showed improvements in learning and memory problems, though real-world data on it today are limited.

Telegram

Have a question about Vinburnine?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC19H22N2O
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.